You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 3, March 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vision Loss Associated With Amantadine Hydrochloride

J. T. Pearlman, MD
Jules Stein Eye Institute 800 Westwood Plaza Los Angeles, CA 90024

A. H. Kadish, MD
9201 W. Sunset Blvd Los Angeles, CA 90069

J. C. Ramseyer, MD
Hospital of The Good Samaritan 616 S Witmer St Los Angeles, CA 90017

Arch Neurol. 1977;34(3):199-200.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor—

Amantadine hydrochloride (Symmetrel) has two separate and apparently unrelated clinical uses: it is most commonly used to control the tremor of Parkinson disease, and it has an antiviral action in the prevention of Asian influenza. Blurring of vision has been reported as an infrequent complication of the drug. The mechanism causing this problem is unknown.

Report of a Case.—

The patient, a 67-year-old man, was first seen in 1973 for a routine eye examination. Apart from a mild astigmatic refractive error and the normal presbyopia of his age, his findings were completely within normal limits. He was seen again in August 1975 for a superficial corneal abrasion of the right eye, which cleared spontaneously without sequelae. In September 1975, his vision was fully correctable to 20/20 in each eye, with no evidence of incipient cataracts, glaucoma, macular degeneration of the retina, or optic nerve disease.

In November . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.